Latest News
Breaking news and real-time updates from the ASX small-cap market
Constellation Resources Confirms Methane and Helium Prospectivity in New Exploration Area
Constellation Resources confirms NatH2, helium and methane prospectivity in SPA-0143; CSIRO results; DMPE grants preferred applicant status; surveys planned 2H26.
KALiNA Power Welcomes New Canadian Regulatory Framework on Carbon Management and Emissions
KALiNA Power eyes Alberta-Canada carbon framework; CFDs and CCS incentives could unlock investment for its 200MW gas plants and data-centre ties (ASX: KPO).
Eden Innovations Taps Tony G to Lead European Defence Push for EdenShield
Eden Innovations taps Tony G to lead EdenShield's European defence push, eyeing govt contracts, EU funds, and landmark partnerships—ASX:EDE moves on.
AFT Pharmaceuticals Targets Minimum $300m Revenue After Record Earnings
AFT Pharmaceuticals targets over $300m revenue in FY27 after record FY26 earnings; Australasia core, expanding international hubs.
Advance Metals Moves Towards Full Ownership of Myrtleford and Beaufort Gold Projects
Advance Metals to gain 100% of Myrtleford/Beaufort after revised deal; $4.07m to 1548043 BC, 1% NSR, amid strong high-grade gold assays.
Comet Ridge Softens Terms and Extends Timelines for Mahalo Acquisition
Comet Ridge chills Mahalo deal: upfront cash cut to $18m + $10m in shares, up to $30m contingent; funding extended to Aug 14, 2026 amid policy uncertainty.
Resolution Minerals Completes First Three Holes of New Golden Gate Drilling Program
Resolution Minerals reports first three Golden Gate holes with encouraging sulphide mineralisation, underpinning a 13,700m drill program.
AnteoTech Validates Ultranode 95 in Commercial Cell Format for Drone and UAV Markets
AnteoTech validates Ultranode 95 in commercial 5Ah cells at BIC: 40% higher energy density, 300+ cycles; boosts drone/UAV battery commercialisation path.
Novatti Group's UNSW Alipay Integration Surpasses Revenue and Transaction Volume Expectations
Novatti's UNSW Alipay integration tops expectations, delivering $33.6m GMV and $0.5m revenue by Apr 30 2026; UNSW first AU uni on Xetta.
Nyrada Announces Preclinical Oncology Efficacy for Xolatryp and US Patent Allowance
Nyrada reports strong preclinical Xolatryp efficacy in liver cancer and a US patent allowance, highlighting a ~39% boost vs doxorubicin alone.
RAS Technology Secures $2M+ Annualised Revenue Boost from New Deals and Contract Extensions
RAS Technology lifts annualised revenue by $2m+ from Altenar, TABtouch, and LeoVegas; Asia momentum fuels growth after H1 38% revenue rise.
OncoSil Medical Secures TGA Approval in Australia for Pancreatic Cancer Device
OncoSil Medical wins TGA approval for OncoSil device to treat unresectable LAPC; ARTG-listed, enabling Australian launch as manufacturing scales up.